Crimson announces publication of Japan Medical Device Digest

NewsGuard 100/100 Score

Crimson Life Sciences, a division of TransPerfect and the world's only ISO 13485 and ISO 14971-certified translation provider, today announced the publication of their Japan Medical Device Digest, a free monthly report that provides English translations of Japanese-language news items.

Found in Translation

Between the ages of 25 and 65, medical device consumption increases by 500% on average. With the world's most rapidly aging population, Japan is an established and growing market for device manufacturers. Regulatory changes now make it easier to serve this market directly, without losing control or profit through distributors, and many US manufacturers are now aggressively expanding in Japan.

However, keeping tabs on competitors' moves in the local market can be a challenge, since much of the published information is in Japanese only. According to Crimson President Marc H. Miller, "Helping US manufacturers monitor the Japanese medical device press is important, since it helps companies to better assess the competitive landscape."

To address this need, Crimson is now offering a free digest of Japanese-language medical device news, translated into English. Explains Miller, "Crimson has a long history of providing resources and information to the medical device industry. Our newly opened Tokyo office, combined with our clients' growth in Japan, made this a natural addition." Crimson's Japan Digest is available in the "Publications" section of the company's website: www.crimsonlanguage.com.

Source:

Crimson Life Sciences

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Can generative AI truly transform healthcare into a more personalized experience?